Skip to main content

Medmain

Category: AI in Healthcare

Medmain offers an AI-powered diagnostic platform that assists radiologists in accurately detecting and analyzing medical images, enhancing clinical decision-making. Medmain was founded in 2018. The company is led by Osamu Iizuka. Based in Paris, France. Team size: 11-50. Total funding raised: $10-15M. Latest round: Series A. Key investors include HealthTech Capital, Innovative Ventures.

Founded
2018
Headquarters
Paris, France
Team size
11-50
Total funding
$10-15M

Value proposition

Improves diagnostic accuracy and reduces time-to-diagnosis, leading to better patient outcomes and streamlined clinical workflows.

Products and solutions

AI diagnostic platform for radiology, CT scan analysis tool, PACS integration solutions

Unique value

Utilizes advanced deep learning algorithms specifically optimized for detecting subtle patterns in medical images.

Target customer

Hospitals, diagnostic imaging centers, and radiology departments

Industries served

Healthcare, Medical Imaging, Radiology

Technology advantage

Proprietary AI models trained on diverse, international datasets with a focus on regulatory compliance and seamless hospital integration.

How they differentiate

Focused on deep regulatory-compliant integration with existing hospital IT systems and strong local partnerships in Europe.

Main competitors

Aidoc, Zebra Medical Vision, Arterys

Key partnerships

Leading European hospital networks, Medical imaging device manufacturers

Notable customers

Major European hospitals and diagnostic centers

Major milestones

Successful clinical trials Obtained key regulatory approvals in the EU Integrated platform in 5 major hospital networks

Growth metrics

Rapid adoption in clinical pilot programs with significant year-over-year revenue growth

Market positioning

Emerging leader in AI-driven radiology diagnostics

Geographic focus

Europe, with plans for broader global expansion

Patents and IP

Pending patents for novel image analysis technologies

About Osamu Iizuka

Osamu Iizuka is the CEO and founder of Medmain Inc. He founded the company in 2018 while he was a medical student at Kyushu University. He was featured in the Forbes 30 Under 30 Asia list in the Healthcare & Science category in 2019.

Official website: